L’articolo è stato aggiunto alla lista dei desideri
LIBRO
E-mail
Facebook
LinkedIn
Twitter
WhatsApp
PS supplements, Pycnogenol, Robuvit, Centellicum. New clinical and preventive applications
(0)
Cliccando su “Conferma” dichiari che il contenuto da te inserito è conforme alle Condizioni Generali d’Uso del Sito ed alle Linee Guida sui Contenuti Vietati. Puoi rileggere e modificare e successivamente confermare il tuo contenuto. Tra poche ore lo troverai online (in caso contrario verifica la conformità del contenuto alle policy del Sito).
Grazie per la tua recensione!
Tra poche ore la vedrai online (in caso contrario verifica la conformità del testo alle nostre linee guida). Dopo la pubblicazione per te +4 punti 
19,00 €
-5%
20,00 €
+190
punti
Venditore: IBS
Articolo acquistabile con Carta del Docente
Articolo acquistabile con Carta Cultura Giovani e Carta del Merito
Dati e Statistiche
Salvato in 0 liste dei desideri
Salvato in 0 liste dei desideri
PS supplements, Pycnogenol, Robuvit, Centellicum. New clinical and preventive applications
Attualmente non disponibile
19,00 €
-5%
20,00 €
19,00 €
20,00 €
-5%
Attualmente non disp.
PS supplements, Pycnogenol, Robuvit, Centellicum. New clinical and preventive applications
Libri
Tutti i formati ed edizioni
Promo attive (1)
Supplementation with PS supplements (supplements with pharmaceutical standards) must follow some new rules concerning the quality of the products and their pharmaceutical consistency. The new field of ‘supplementary medicine’ - based on PS supplements - is expanding, replacing many alternative or complementary methods associated to poor science, limited results or without evidence. Supplement studies (usually registries) define the field of activity of PS supplements and possible, preventive, preferably non-clinical or pre-clinical applications. They are planned and organized with the full attention and participation of the evaluation subjects. Safety is the first point to define. All PS supplements are by definition recognized as safe (RAS). The best fields of application for PS supplements are preclinical, borderline ‘preventive’ applications or the supplementary management of some risk conditions. Supplements - unless there are specific claims - are not generally used as the main standard treatments of signs/symptoms or severe clinical conditions. Supplementary medicine and PS supplements are the new method & tools to perform a softer, effective and low-risk, shared, com-part medicine. PS supplements are not drugs (all drugs are quoted in the Goodman & Gilman’s: The Pharmacological Basis of Therapeutics; Mc Graw Hill). PS supplements create a bright clinical and business future.
Leggi di più
Leggi di meno
Editore:
Anno edizione:
2019
In commercio dal:
1 gennaio 2019
Tipo:
Libro universitario
Pagine:
126 p., ill. , Brossura
EAN:
9788877119865
Indice
PROSTATIC FIBROSIS; IMPROVEMENT IN TISSUE MORPHOLOGY AND SYMPTOMS OF ENLARGED PROSTATE WITH THE COMBINATION PYCNOGENOL® AND CENTELLICUM®
Ledda A., Dugall M., Hu S., Belcaro G., Peterzan P., Hosoi M., Cotellese R., Cesarone M. R., Scipione C., Scipione V.
SUPPLEMENTARY MANAGEMENT IN SUBJECTS WITH PARKINSON’S DISEASE AND MILD COGNITIVE IMPAIRMENT WITH PYCNOGENOL®
Cesarone M. R., Belcaro G., Hu S., Hosoi M., Ledda A., Feragalli B., Zuccarini M., Luzzi R.
EXPLORING THE CONCEPT OF VIGOR AND DYS-VIGOR IN MEN OF 50-65 YEARS: EFFECTS OF ROBUVIT®
Hosoi M., Cesarone M. R,. Dugall M., Hu S., Belcaro G., Peterzan P., Cotellese R.
CENTRAL CARDIOVASCULAR CALCIFICATIONS VARIATIONS IN 12 MONTHS WITH PYCNOGENOL®-CENTELLICUM® SUPPLEMENTATION
Hu S., Belcaro G., Cesarone M.R., Feragalli B., Cotellese R., Dugall M.
PROGRESSION AND OCCURRENCE OF CARDIOVASCULAR EVENTS IN ASYMPTOMATIC PATIENTS WITH ATHEROSCLEROTIC PLAQUES; EFFECTS OF THE COMBINED SUPPLEMENTATION WITH PYCNOGENOL®+CENTELLICUM®
Cesarone M.R., Dugall M., Hu S., Belcaro G., Peterzan P., Luzzi R., Hosoi M., Cotellese R.
PYCNOGENOL®+CENTELLICUM®, POST-STENTS EVALUATION. CONTROL OF NEOINTIMA AND PLAQUE RE-GROWTH AT 12 MONTHS
Cesarone M.R., Dugall M., Hu S., Belcaro G., Peterzan P.,Feragalli B., Luzzi R., Hosoi M., Cotellese R.
EPISODIC PRIMARY MIGRAINE HEADACHE: PROPHYLAXIS WITH PYCNOGENOL® PRECENTS ATTACKS AND CONTROLS OXIDATIVE STRESS
Cesarone M.R., Dugall M., Hu S., Belcaro G., Peterzan P., Luzzi R., Hosoi M., Cotellese R.
XEROSTOMIA AND PYCNOGENOL® SUPPLEMENTATION A PILOT, CONCEPT STUDY
Belcaro G., Cesarone M.R., Dugall M., Hu S., Peterzan P., Feragalli B., Luzzi R., Hosoi M., Cotellese R.
MILD HEART FAILURE: EFFECTS OF ROBUVIT® IN A PILOT REGISTRY
Cesarone M.R., Belcaro G., Dugall M., Hu S., Corsi M., Hosoi M., Luzzi R., Cotellese R., Olivier Ni., Feragalli B., Ledda A.
PRIMARY SPONTANEOUS EDEMA OF PROBABLE LYMPHATIC ORIGIN. A CONCEPT, REGISTRY STUDY. EFFECTS OF ROBUVIT® IN DIFFUSE, MINIMAL LYMPHATIC ‘RETENTION’ (DMLR)
Hu S., Belcaro G., Hosoi M., Cesarone M.R., Dugall M., Peterzan P., Cotellese R.
HANGOVER AND FATIGUE; EFFECTIVENESS OF ROBUVIT® SUPPLEMENTATION
Hosoi M., Cornelli U., Hu S., Belcaro G., Cesarone M.R., Pellegrini L., Dugall M., Peterzan P., Cotellese R.
A SUPPLEMENTARY APPROACH TO VAGINAL DRYNESS IN HEALTHY PERI-MENOPAUSAL WOMEN WITH LADY PRELOX® 4
Cesarone M.R., Belcaro G., Cornelli U., Dugall M., Hu S., Corsi M., Hosoi M., Luzzi R., Cotellese R., Feragalli B., Ledda A.
SUPPLEMENTARY MANAGEMENT WITH PYCNOGENOL® OF PATIENTS IN REMISSION PHASES OF LUPUS VASCULITIS: A PILOT REGISTRY STUDY
Cesarone M.R., Belcaro G., Hu S., Hosoi M., Ledda A., Feragalli B., Zuccarini M., Luzzi R.
Ledda A., Dugall M., Hu S., Belcaro G., Peterzan P., Hosoi M., Cotellese R., Cesarone M. R., Scipione C., Scipione V.
SUPPLEMENTARY MANAGEMENT IN SUBJECTS WITH PARKINSON’S DISEASE AND MILD COGNITIVE IMPAIRMENT WITH PYCNOGENOL®
Cesarone M. R., Belcaro G., Hu S., Hosoi M., Ledda A., Feragalli B., Zuccarini M., Luzzi R.
EXPLORING THE CONCEPT OF VIGOR AND DYS-VIGOR IN MEN OF 50-65 YEARS: EFFECTS OF ROBUVIT®
Hosoi M., Cesarone M. R,. Dugall M., Hu S., Belcaro G., Peterzan P., Cotellese R.
CENTRAL CARDIOVASCULAR CALCIFICATIONS VARIATIONS IN 12 MONTHS WITH PYCNOGENOL®-CENTELLICUM® SUPPLEMENTATION
Hu S., Belcaro G., Cesarone M.R., Feragalli B., Cotellese R., Dugall M.
PROGRESSION AND OCCURRENCE OF CARDIOVASCULAR EVENTS IN ASYMPTOMATIC PATIENTS WITH ATHEROSCLEROTIC PLAQUES; EFFECTS OF THE COMBINED SUPPLEMENTATION WITH PYCNOGENOL®+CENTELLICUM®
Cesarone M.R., Dugall M., Hu S., Belcaro G., Peterzan P., Luzzi R., Hosoi M., Cotellese R.
PYCNOGENOL®+CENTELLICUM®, POST-STENTS EVALUATION. CONTROL OF NEOINTIMA AND PLAQUE RE-GROWTH AT 12 MONTHS
Cesarone M.R., Dugall M., Hu S., Belcaro G., Peterzan P.,Feragalli B., Luzzi R., Hosoi M., Cotellese R.
EPISODIC PRIMARY MIGRAINE HEADACHE: PROPHYLAXIS WITH PYCNOGENOL® PRECENTS ATTACKS AND CONTROLS OXIDATIVE STRESS
Cesarone M.R., Dugall M., Hu S., Belcaro G., Peterzan P., Luzzi R., Hosoi M., Cotellese R.
XEROSTOMIA AND PYCNOGENOL® SUPPLEMENTATION A PILOT, CONCEPT STUDY
Belcaro G., Cesarone M.R., Dugall M., Hu S., Peterzan P., Feragalli B., Luzzi R., Hosoi M., Cotellese R.
MILD HEART FAILURE: EFFECTS OF ROBUVIT® IN A PILOT REGISTRY
Cesarone M.R., Belcaro G., Dugall M., Hu S., Corsi M., Hosoi M., Luzzi R., Cotellese R., Olivier Ni., Feragalli B., Ledda A.
PRIMARY SPONTANEOUS EDEMA OF PROBABLE LYMPHATIC ORIGIN. A CONCEPT, REGISTRY STUDY. EFFECTS OF ROBUVIT® IN DIFFUSE, MINIMAL LYMPHATIC ‘RETENTION’ (DMLR)
Hu S., Belcaro G., Hosoi M., Cesarone M.R., Dugall M., Peterzan P., Cotellese R.
HANGOVER AND FATIGUE; EFFECTIVENESS OF ROBUVIT® SUPPLEMENTATION
Hosoi M., Cornelli U., Hu S., Belcaro G., Cesarone M.R., Pellegrini L., Dugall M., Peterzan P., Cotellese R.
A SUPPLEMENTARY APPROACH TO VAGINAL DRYNESS IN HEALTHY PERI-MENOPAUSAL WOMEN WITH LADY PRELOX® 4
Cesarone M.R., Belcaro G., Cornelli U., Dugall M., Hu S., Corsi M., Hosoi M., Luzzi R., Cotellese R., Feragalli B., Ledda A.
SUPPLEMENTARY MANAGEMENT WITH PYCNOGENOL® OF PATIENTS IN REMISSION PHASES OF LUPUS VASCULITIS: A PILOT REGISTRY STUDY
Cesarone M.R., Belcaro G., Hu S., Hosoi M., Ledda A., Feragalli B., Zuccarini M., Luzzi R.
L'articolo è stato aggiunto al carrello
L’articolo è stato aggiunto alla lista dei desideri
